A letter in response to the recently published article entitled “Effect of elexacaftor/tezacaftor/ivacaftor on annual rate of lung function decline in people with cystic fibrosis
Association between nebulizer therapies adherence and visit-to-visit variability of lung function in patients with cystic fibrosis
What do dietitians, doctors and physiotherapists think about the management of people with CF who are living with overweight and obesity?
More favorable growth profiles in early childhood are associated with higher lung function at age six
Understanding Medical Traumatic Stress in Cystic Fibrosis from the Viewpoints of Patients, Families, and Providers
